300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Ghana
Iraq
Denmark
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Tanzania
Senegal
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Angola
Europe
Bangladesh
Cyprus
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Qatar
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Iceland
Israel
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Wyss Center, VC Fund

Wyss Center

VC Fund

Geneva, Switzerland

Wyss Center is a VC fund in Geneva focused on Medical and Manufacturing. Epios personalized and precision management of brain disorders using daily life monitoring and therapeutics. The Epios system comprises a series of thin leads incorporating sensing electrodes and a miniature implant, inserted beneath the skin. The neural signals are wirelessly transmitted to an external receiver held in place on the skin directlyover the implant with a magnet, and from there are conveyed to a wearable data processor and are finally securely stored in the Epios Cloud.

Total investments:
5
Last investment:
Lead investor:
20%

Last updated:

Industries Wyss Center invests in

MedicalManufacturingMedical DeviceFitnessSecurity

Stages Wyss Center invests in

SeedGrantSeries A

Countries Wyss Center invests in

Switzerland

Round sizes

Grant $109k–$109k

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Round size

Grant
$109k–$109k

Investment Focus

Industry

  • Medical 2 (40%)
  • Manufacturing 2 (40%)
  • Medical Device 2 (40%)
  • Fitness 1 (20%)
  • Security 1 (20%)
See all 11 industries →

Stage

  • Seed 2 (40%)
  • Grant 2 (40%)
  • Series A 1 (20%)

Team

NameTitleInvestmentsLinksEmail
Erwin Böttinger
Erwin Böttinger Chief Executive Officer
Chief Executive Officer Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
Clee Medical Clee Medical
Clee Medical believes the rapid growth of neurotech is constrained by inefficiencies in surgical tools and techniques. Seed / Feb 25, 2026
Deegtal Deegtal
dEEGtal’s use of AI to expedite epilepsy diagnosis could make a significant difference in patient care, by analyzing EEG data quickly, it might help identify patterns or anomalies that could be missed by human reviewers alone. $1.1M / Seed / Dec 13, 2024
ARTIRIA Medical ARTIRIA Medical
ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases. $6M / Series A / Feb 27, 2024
Bearmind Bearmind
Bearmind developing technology for monitoring and real-time analysis of head impact in athletes. $109.3K / Grant / Sep 06, 2021
Oniri Oniri
A mobile application to help people remember, understand and control their dreams. $109.3K / Grant / Sep 06, 2021

Co-Investors

4FOX Ventures 4FOX Ventures 2 deals together
Federal Polytechnic School of Lausanne Federal Polytechnic School of Lausanne 2 deals together
Wyss Center Wyss Center 2 deals together
Zürcher Kantonal Bank Zürcher Kantonal Bank 2 deals together
Business Angels Switzerland (BAS) Business Angels Switzerland (BAS) 1 deal together
FONGIT FONGIT 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Ghana
Iraq
Denmark
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Tanzania
Senegal
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Argentina
Angola
Europe
Bangladesh
Cyprus
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Qatar
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Iceland
Israel
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Wyss Center invest in?

Wyss Center invests primarily in Medical, Manufacturing and Medical Device startups, most often at Seed and Grant stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Wyss Center's check size?

Wyss Center typically joins rounds of $109k–$109k at Grant. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wyss Center participates in.

How do I contact Wyss Center?

Public channels for Wyss Center include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Wyss Center?

The team at Wyss Center includes Erwin Böttinger (Chief Executive Officer). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Wyss Center Wyss Center Find emails